Search Results

Displaying results 21 - 31 of 31

Sort by:

Published dateDatasourceRelevance

EFFECTS OF CANAGLIFLOZIN ON STROKE IN THE CREDENCE TRIAL
03/2020 -
Publication
entity:bibcite_reference
0
EFFECTS OF CANAGLIFLOZIN ON CARDIOVASCULAR, RENAL AND SAFETY OUTCOMES BY BASELINE LOOP DIURETIC USE: DATA FROM THE CREDENCE TRIAL
03/2020 -
Publication
entity:bibcite_reference
0
THE EFFECTS OF CANAGLIFLOZIN ON HEART FAILURE AND CARDIOVASCULAR DEATH BY BASELINE PARTICIPANT CHARACTERISTICS: ANALYSIS OF THE CREDENCE TRIAL
03/2020 -
Publication
entity:bibcite_reference
0
Kidney and cardiovascular protection with SGLT2 inhibitors: lessons from cardiovascular outcome trials and CREDENCE
Publication
entity:bibcite_reference
0
CANAGLIFLOZIN AND RISK OF GENITAL INFECTIONS AND URINARY TRACT INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE- A POST-HOC ANALYSIS OF THE CREDENCE TRIAL
06/2020 -
Publication
entity:bibcite_reference
0
CANAGLIFLOZIN AND RISK OF SKIN AND SOFT TISSUE INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE - A POST-HOC ANALYSIS OF THE CREDENCE TRIAL
06/2020 -
Publication
entity:bibcite_reference
0
Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE Trial
Publication
entity:bibcite_reference
0
Abstract P201: Canagliflozin, Visit-to-visit Blood Pressure Variability, And Risk Of Cardiovascular, Kidney, And Mortality Outcomes: Pooled Individual Participant Data From The CANVAS And CREDENCE Trials
Publication
entity:bibcite_reference
0
Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial
Publication
entity:bibcite_reference
0
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials.
Publication
entity:bibcite_reference
0
Brendon Neuen
Associate Professor Brendon Neuen is a Staff Specialist Nephrologist and Director of Kidney Trials at Royal North Shore Hospital and Senior Research Fellow at The George Institute for Global Health.…
entity:user
0